Previous studies have demonstrated that PLPP2 could regulate tumor growth by modulating cell-cycle progression; knockdown of PLPP2 in breast cancer cells resulted in reduced c-myc expression and inhibition of G1 to S phase transition [20]. The gene discussed is PLPP2; the disease is neoplasm.